Growth Metrics

Bio-Techne (TECH) Shareholder's Equity Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.33%
Dec 31, 2025 -3.25%
Sep 30, 2025 -8.08%
Jun 30, 2025 -7.25%
Mar 31, 2025 0.18%
Dec 31, 2024 5.85%
Sep 30, 2024 7.05%
Jun 30, 2024 5.20%
Mar 31, 2024 6.60%
Dec 31, 2023 7.47%
Sep 30, 2023 14.08%
Jun 30, 2023 15.61%
Mar 31, 2023 10.29%
Dec 31, 2022 7.32%
Sep 30, 2022 6.33%
Jun 30, 2022 8.26%
Mar 31, 2022 10.68%
Dec 31, 2021 11.21%
Sep 30, 2021 14.43%
Jun 30, 2021 13.76%
Mar 31, 2021 19.88%
Dec 31, 2020 15.68%
Sep 30, 2020 22.57%
Jun 30, 2020 18.50%
Mar 31, 2020 12.65%
Dec 31, 2019 20.70%
Sep 30, 2019 5.84%
Jun 30, 2019 8.02%
Mar 31, 2019 8.31%
Dec 31, 2018 9.88%
Sep 30, 2018 15.56%
Jun 30, 2018 13.63%
Mar 31, 2018 16.56%
Dec 31, 2017 12.04%
Sep 30, 2017 7.23%
Jun 30, 2017 8.00%
Mar 31, 2017 6.44%
Dec 31, 2016 4.00%
Sep 30, 2016 6.85%
Jun 30, 2016 3.82%
Mar 31, 2016 4.01%
Dec 31, 2015 4.35%
Sep 30, 2015 5.61%
Jun 30, 2015 6.50%
Mar 31, 2015 5.54%
Dec 31, 2014 9.64%
Sep 30, 2014 9.17%
Jun 30, 2014 7.83%
Mar 31, 2014 8.00%
Dec 31, 2013 7.77%
Sep 30, 2013 6.78%
Jun 30, 2013 9.36%
Mar 31, 2013 11.64%
Dec 31, 2012 16.24%
Sep 30, 2012 15.48%
Jun 30, 2012 15.07%
Mar 31, 2012 13.81%
Dec 31, 2011 10.25%
Sep 30, 2011 12.57%
Jun 30, 2011 16.81%
Jun 30, 2010 9.93%